Frank D. Lee

Sits on 3 boards. Last updated September 28, 2026

Time on boards

Boards served
3
Current seats
3
Board service
9 years
Director since
2023

9 years of board service in total across 3 boards, counting each seat separately. Longest: Bolt Biotherapeutics Inc., 3 years.

3 years · Since 2023
Pacira BioSciences Inc. Director · Chief Executive Officer
2 years · Since 2024
2 years · Since 2024

Chief executive roles

Pacira BioSciences Inc. · Chief Executive Officer
Since January 2024
32 CEO score

Weak · grade F

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 35% of the scoring weight is on file.

Revenue growth 20%
56

3.7% a year in revenue

Earnings growth 15%
0

-57.6% a year in earnings per share

35% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Nov 17, 2026 Pacira BioSciences Inc. Sold back to the company −660,831 $36.50 $24,120,326
May 22, 2026 Bausch Health Companies Inc. Grant or award +45,871 — —
May 19, 2026 Bausch Health Companies Inc. Open-market sale −24,456 $5.43 $132,796
Feb 11, 2026 Pacira BioSciences Inc. Grant or award +261,818 — —
Jan 30, 2026 Pacira BioSciences Inc. Shares withheld for tax −41,488 $20.54 $852,164
Jan 2, 2026 Pacira BioSciences Inc. Shares withheld for tax −9,272 $24.46 $226,793
Aug 21, 2025 Bausch Health Companies Inc. Open-market sale −15,912 $7.66 $121,886
May 16, 2025 Bausch Health Companies Inc. Grant or award +54,347 — —
Feb 1, 2025 Pacira BioSciences Inc. Grant or award +350,000 — —
Jan 2, 2025 Pacira BioSciences Inc. Shares withheld for tax −9,375 $18.33 $171,844
Aug 12, 2024 Pacira BioSciences Inc. Open-market purchase +8,264 $12.10 $99,994
May 17, 2024 Bausch Health Companies Inc. Grant or award +35,360 — —
Jan 2, 2024 Pacira BioSciences Inc. Grant or award +99,520 — —

Questions about Frank D. Lee

What boards is Frank D. Lee on?

Frank D. Lee sits on the boards of Bausch Health Companies Inc., Bolt Biotherapeutics Inc. and Pacira BioSciences Inc.

What company is Frank D. Lee the CEO of?

Frank D. Lee has been Chief Executive Officer of Pacira BioSciences Inc. since January 2024.

How long has Frank D. Lee served on boards?

Our records show at least 9 years of board service across 3 boards, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.